Bernardini, N.; Dattola, A.; Rossi, R.; Pagnanelli, G.; Amerio, P.; Atzori, L.; Mugheddu, C.; Lora, V.; Giordano, D.; Guacci, L.F.;
et al. Efficacy and Safety of Intra-Class Switching from Ixekizumab to Secukinumab in Patients with Plaque Psoriasis: A Multicenter Retrospective Study. J. Pers. Med. 2024, 14, 1169.
https://doi.org/10.3390/jpm14121169
AMA Style
Bernardini N, Dattola A, Rossi R, Pagnanelli G, Amerio P, Atzori L, Mugheddu C, Lora V, Giordano D, Guacci LF,
et al. Efficacy and Safety of Intra-Class Switching from Ixekizumab to Secukinumab in Patients with Plaque Psoriasis: A Multicenter Retrospective Study. Journal of Personalized Medicine. 2024; 14(12):1169.
https://doi.org/10.3390/jpm14121169
Chicago/Turabian Style
Bernardini, Nicoletta, Annunziata Dattola, Raimondo Rossi, Gianluca Pagnanelli, Paolo Amerio, Laura Atzori, Cristina Mugheddu, Viviana Lora, Domenico Giordano, Lucia Finistauri Guacci,
and et al. 2024. "Efficacy and Safety of Intra-Class Switching from Ixekizumab to Secukinumab in Patients with Plaque Psoriasis: A Multicenter Retrospective Study" Journal of Personalized Medicine 14, no. 12: 1169.
https://doi.org/10.3390/jpm14121169
APA Style
Bernardini, N., Dattola, A., Rossi, R., Pagnanelli, G., Amerio, P., Atzori, L., Mugheddu, C., Lora, V., Giordano, D., Guacci, L. F., Persechino, S., Richetta, A. G., Skroza, N., & Potenza, C.
(2024). Efficacy and Safety of Intra-Class Switching from Ixekizumab to Secukinumab in Patients with Plaque Psoriasis: A Multicenter Retrospective Study. Journal of Personalized Medicine, 14(12), 1169.
https://doi.org/10.3390/jpm14121169
